drugset / Trial / NCT01456299

Laryngeal Mask Airway (LMA) Insertion With Sevoflurane and Remifentanil

NCT01456299 ↗

Completed 102 enrolled Gachon University Gil Medical Center
RandomizedParallel-groupSingle-blindOther

Summary

The purpose of this study was to determine the most suitable effect-site concentration of remifentanil for the LMA insertion during inhaled induction with 8% sevoflurane in adults.

Timeline

Start
2011-04
Primary completion
2011-12
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Remifentanil Small molecule 1 ng/ml —
Comparator Remifentanil Small molecule 2 ng/ml —

Indications